Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
3
×
national blog main
national top stories
new york top stories
biotech
boston blog main
boston top stories
fda
new york blog main
san francisco top stories
abbvie
acorda therapeutics
akcea therapeutics
alnylam pharmaceuticals
ampyra
apokyn
apomorphine
barry greene
billy dunn
biogen
boston
boston university
dalfampridine
dan ollendorf
drug prices
drug pricing
drugs
duopa
europe top stories
evrysdi
gene therapy
genentech
hereditary transthyretin amyloidosis
inbrija
inotersen
ionis pharmaceuticals
john berk
mary o'donnell
mylan
What
fda
friday
3
×
patients
3
×
approved
drug
medicine
new
acorda
ago
alnylam
approve
atrophy
awaits
biological
cope
crossed
daily
decades
decision
discovered
disease
episodes
evrysdi
fingers
gets
green
help
historic
home
intended
late
lights
liquid
looms
meant
medications
muscular
nod
oral
parkinson’s
Language
unset
Current search:
friday
×
" life sciences "
×
patients
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision